share_log

At US$69.43, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

At US$69.43, Is It Time To Put Merit Medical Systems, Inc. (NASDAQ:MMSI) On Your Watch List?

价格为69.43美元,是时候将Merit Medical Systems, Inc.(纳斯达克股票代码:MMSI)列入你的观察名单了吗?
Simply Wall St ·  2022/12/29 07:50

Merit Medical Systems, Inc. (NASDAQ:MMSI), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGS over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine Merit Medical Systems's valuation and outlook in more detail to determine if there's still a bargain opportunity.

Merit Medical Systems, Inc.(纳斯达克股票代码:MMSI)可能不是大盘股,但纳斯达克指数在过去几个月中大幅上涨引起了广泛关注。由于许多分析师都在报道中型股,我们可能预计,任何对价格敏感的公告都已计入该股的股价。但是,这只股票还能以相对便宜的价格交易吗?让我们更详细地研究一下Merit Medical Systems的估值和前景,以确定是否还有讨价还价的机会。

See our latest analysis for Merit Medical Systems

查看我们对 Merit 医疗系统的最新分析

What Is Merit Medical Systems Worth?

Merit医疗系统值多少钱?

According to my valuation model, the stock is currently overvalued by about 20%, trading at US$69.43 compared to my intrinsic value of $57.69. This means that the buying opportunity has probably disappeared for now. But, is there another opportunity to buy low in the future? Given that Merit Medical Systems's share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

根据我的估值模型,该股目前被高估了约20%,交易价格为69.43美元,而我的内在价值为57.69美元。这意味着买入机会目前可能已经消失了。但是,未来还有其他低价买入的机会吗?鉴于Merit Medical Systems的份额相当不稳定(即与其他市场相比,其价格变动被放大),这可能意味着价格可能会下跌,这使我们有机会在未来再次买入。这是基于其高贝塔值,这是衡量股价波动的好指标。

What kind of growth will Merit Medical Systems generate?

Merit Medical Systems将带来什么样的增长?

earnings-and-revenue-growth
NasdaqGS:MMSI Earnings and Revenue Growth December 29th 2022
纳斯达克股票代码:MMSI 收益和收入增长 2022 年 12 月 29 日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Merit Medical Systems' earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

寻求投资组合增长的投资者在购买公司股票之前可能需要考虑公司的前景。尽管价值投资者会争辩说,最重要的是相对于价格的内在价值,但更有说服力的投资论点是以低廉的价格获得高增长潜力。预计未来几年,Merit Medical Systems的收益将翻一番,这表明未来的前景非常乐观。这应该会带来更强的现金流,从而带来更高的股票价值。

What This Means For You

这对你意味着什么

Are you a shareholder? MMSI's optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe MMSI should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

你是股东吗? MMSI的乐观未来增长似乎已计入当前股价,股票交易价格高于其公允价值。但是,这又带来了另一个问题——现在是卖出的合适时机吗?如果你认为MMSI应该以低于其当前价格进行交易,那么高价卖出并在其价格跌至实际价值时再次回购可能是有利可图的。但是在做出这个决定之前,先看看它的基本面是否发生了变化。

Are you a potential investor? If you've been keeping tabs on MMSI for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there's no upside from mispricing. However, the optimistic prospect is encouraging for MMSI, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

你是潜在的投资者吗? 如果你关注MMSI已有一段时间了,那么现在可能不是进入该股的最佳时机。价格已经超过了其真实价值,这意味着错误定价没有任何好处。但是,对于MMSI来说,乐观的前景令人鼓舞,这意味着值得更深入地研究其他因素,以利用下一次价格下跌的机会。

So while earnings quality is important, it's equally important to consider the risks facing Merit Medical Systems at this point in time. In terms of investment risks, we've identified 1 warning sign with Merit Medical Systems, and understanding it should be part of your investment process.

因此,尽管收益质量很重要,但考虑Merit Medical Systems目前面临的风险同样重要。在投资风险方面, 我们已经发现了 1 个警告标志 选择 Merit Medical Systems,了解这应该是你投资过程的一部分。

If you are no longer interested in Merit Medical Systems, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您不再对Merit Medical Systems感兴趣,可以使用我们的免费平台查看我们列出的其他50多只具有高增长潜力的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧? 取得联系 直接和我们联系。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是一般性的。 我们仅使用不偏不倚的方法根据历史数据和分析师预测提供评论,我们的文章并非旨在提供财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能未将最新的价格敏感型公司公告或定性材料考虑在内。简而言之,华尔街对上述任何股票都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发